CHCT:NYE-Community Healthcare Trust Incorporated (USD)

COMMON STOCK | REIT—Healthcare Facilities | NYE

Last Closing Price

USD 47.09

Change

0.00 (0.00)%

Market Cap

USD 0.95B

Volume

0.10M

Average Target Price

USD 46.25 (-1.78%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in non-urban markets throughout the United States. The Company had investments of approximately $566.3 million in 111 real estate properties as of September 30, 2019, located in 32 states, totaling approximately 2.5 million square feet.

Market Stats

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-12-07 )

Largest Industry Peers for REIT—Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HTA Healthcare Trust of America, I..

N/A

USD2.06B 172.25 22.06
LTC LTC Properties, Inc

N/A

USD1.88B 19.16 18.61
UHT Universal Health Realty Income..

N/A

USD1.68B 96.04 35.05
GEO The GEO Group, Inc

N/A

USD1.64B 9.92 10.31
OHI Omega Healthcare Investors, In..

N/A

USD0.69B 26.06 18.03
GMRE-PA Global Medical REIT Inc

N/A

USD0.43B 86.48 31.39
HR Healthcare Realty Trust Incorp..

N/A

USD0.15B 159.66 23.80
VTR Ventas, Inc

N/A

USD-53,698,560.00 43.41 18.51
WELL Welltower Inc

N/A

USD-365,873,152.00 29.94 21.58
DOC Physicians Realty Trust

N/A

USD-673,083,136.00 82.99 20.69

ETFs Containing CHCT

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (REIT—Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 63.34% 92% A- 94% A
Dividend Return 5.70% 75% C 83% B
Total Return 69.03% 92% A- 95% A
Trailing 12 Months  
Capital Gain 51.76% 92% A- 94% A
Dividend Return 5.29% 75% C 80% B-
Total Return 57.05% 92% A- 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 21.12% 100% A+ 92% A-
Dividend Return 6.03% 75% C 86% B
Total Return 27.16% 100% A+ 94% A
Risk Return Profile  
Volatility (Standard Deviation) 16.56% 75% C 47% F
Risk Adjusted Return 164.01% 100% A+ 98% A+
Market Capitalization 0.95B 69% D+ 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(REIT—Healthcare Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 288.90 8% F 2% F
Price/Book Ratio 3.01 23% F 30% F
Price / Cash Flow Ratio 39.07 15% F 6% F
EV/EBITDA 30.03 23% F 11% F
Management Effectiveness  
Return on Equity 1.47% 15% F 27% F
Return on Invested Capital 3.37% 31% F 30% F
Return on Assets 2.09% 31% F 41% F
Debt to Equity Ratio 38.57% 100% A+ 71% C-
Technical Ratios  
Short Ratio 5.91 33% F 20% F
Short Percent 4.61% 42% F 62% D-
Beta 0.70 23% F 65% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector